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The natural response to itch sensation is to scratch,
which relieves the itch through an unknown mecha-
nism. Interaction between pain and itch has been
frequently demonstrated, and the selectivity hypoth-
esis of itch, based on data from electrophysiological
and behavioral experiments, postulates the exis-
tence of primary pain afferents capable of repressing
itch. Here, we demonstrate that deletion of vesicular
glutamate transporter (VGLUT) 2 in a subpopulation
of neurons partly overlapping with the vanilloid
receptor (TRPV1) primary afferents resulted in
a dramatic increase in itch behavior accompanied
by a reduced responsiveness to thermal pain. The
increased itch behavior was reduced by administra-
tion of antihistaminergic drugs and by genetic
deletion of the gastrin-releasing peptide receptor,
demonstrating a dependence on VGLUT2 tomaintain
normal levels of both histaminergic and nonhistami-
nergic itch. This study establishes that VGLUT2 is
a major player in TRPV1 thermal nociception and
also serves to regulate a normal itch response.
INTRODUCTION
Pain and itch are two critical modalities of sensory input, and
improper function of nociceptive and pruriceptive transmission
may have severe consequences. For example, loss of pain
sensation increases the risk of exposing our bodies to harmful
tissue damage, and, similarly, loss of itch sensation deprives
us of a warning signal of an offending stimulus. Further, exagger-
ated scratching in response to increased levels of perceived itch
in skin disorders can induce self-feeding itch-scratch cycles that
damage the skin and worsen the condition (Ikoma et al., 2006).
There is a shortage of therapeutically efficient treatments for
both itch and chronic pain, calling for a deeper understanding
of how the underlying circuitry is organized and how it functions.
The delivery of itch and pain sensations starts with primary
afferents located in the dorsal root ganglia (DRG), which transmittheir information to the brain via second-order neurons including
spinothalamic tract (STT) neurons in the dorsal horn. While the
pathways, mechanisms, and populations of neurons responsible
for transmitting pain have been under intense investigation for
several decades and are reasonably well understood, a similar
level of understanding regarding pruriception is lacking.
Three theories regarding the transmission of itch have been
proposed: the intensity, the specificity, and the selectivity
theories (McMahon and Koltzenburg, 1992). The intensity theory,
originally raised by von Frey, postulates that weak stimuli in
nociceptors can transmit itch instead of pain, presumably
through a common central pathway (reviewed in Carstens,
2009). In contrast, datamostly originating from electrophysiolog-
ical recordings in humans have led to the specificity theory,
which suggests that exclusive pruriceptors exist along with
nociceptors. For instance, itch induced by focal electrical stimu-
lation of the skin or in single neurons becomes more intense as
the stimulation frequency increases, but it does not transform
into pain (Ikoma et al., 2005; Tuckett, 1982). In addition, an
itch-specific signaling pathway from the periphery to the spinal
cord dorsal horn, mediated by the gastrin-releasing peptide
(GRP) (and its receptor), has been identified (Sun and Chen,
2007; Sun et al., 2009). Furthermore, two components in a hista-
mine-specific route to higher brain areas have been identified,
a population of C fibers (Schmelz et al., 1997) and a set of spino-
thalamic tract neurons (Andrew and Craig, 2001), findings that
support the idea of specificity. However, histamine-sensitive C
fibers were later demonstrated to be selective, rather than
specific, for pruritogens (Schmelz et al., 2003). This finding fits
with the third theory, which suggests the presence of fibers
that are pain selective along with fibers transmitting both itch
and pain (McMahon and Koltzenburg, 1992), although, as previ-
ously suggested, a mixture of the specificity and selectivity theo-
ries might be more accurate (Schmelz, 2001).
The selectivity theory also addresses afferent pain fibers,
which have been hypothesized to mediate reduction of itch
signaling (McMahon and Koltzenburg, 1992). Interaction
between pain and itch has been frequently demonstrated, where
the sensation of itch can be inhibited by various painful stimuli
including vigorous scratching, cooling, mustard oil, noxious
heat, and electrical cutaneous field stimulation (Ward et al.,
1996; Yosipovitch et al., 2007). Conversely, loss of pain sensation
can lead to elevated itch sensation (Atanassoff et al., 1999), forNeuron 68, 529–542, November 4, 2010 ª2010 Elsevier Inc. 529
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VGLUT2 in Pain and Itchexample through intrathecal injections of the opioid agonist
morphine (Raffaeli et al., 2006; Slappendel et al., 2000). While it
is recognized that pruriception is mediated by small-diameter
primary afferent neurons (Han et al., 2006; Schmelz et al., 1997;
Sun and Chen, 2007), the neuronal subpopulations and media-
tors capable of restricting exaggerated itch sensation have not
been identified. Recent data, based on the loss of spinal cord
interneurons in the Bhlhb5 null mice, suggest a model in which
disinhibition in the dorsal spinal cord results in abnormal itch.
Thus, itch behavior resulting fromperipheral activation of primary
afferent pruriceptors can be modulated by central circuits (Ross
et al., 2010). It is presently unknownwhether specific transmitters
that can modulate pruriceptive signals exist.
Most primary afferents are glutamatergic and use a family of
solute carriers, the vesicular glutamate transporters (VGLUT1-3),
to package glutamate into synaptic vesicles. Mice heterozygous
for VGLUT1 do not show any changes in pain behavior (Leo et al.,
2009), which may be related to the finding that VGLUT1 is
predominantly expressed in nonnociceptive neurons (Brumov-
sky et al., 2007). VGLUT2 dominates in nociceptive primary affer-
ents (Brumovsky et al., 2007), and mice heterozygous for Vglut2
display impaired neuropathic pain sensitivity, whereas acute and
inflammatory pain behaviors are unaltered (Moechars et al.,
2006). VGLUT3 is expressed in a small subset of primary afferents
andwas recently related tomechanical pain sensation (Seal et al.,
2009). Becauseof theextensive expressionof VGLUT2 in primary
afferents (Brumovsky et al., 2007; Li et al., 2003), promoter-driven
Cre lineswith restricted expressionmay be used to study the role
of different subpopulations in the DRG by removal of glutamater-
gic transmission. The Nav1.8 population has been associated
with mechanical and inflammatory pain modalities (Abrahamsen
et al., 2008), and our recent work shows that there are both
VGLUT2-dependent and -independent pain modalities within
theNav1.8population (unpublisheddata). Basedon thepresence
of VGLUT in primary afferents associated with pain and itch
(C fibers), we hypothesized that VGLUT2 has a role in mediating
additional submodalities of sensory transmission.
To study the contribution of VGLUT2-mediated signaling in
pain and itch sensations, we investigated mice lacking Vglut2
in the primary sensory subpopulations defined by the expression
of tyrosine hydroxylase (Th), human tissue plasminogen (Ht-Pa),
voltage-gated sodium channel 1.8 (Nav1.8), or transient receptor
potential vanilloid 1 (Trpv1). This allowed for a careful encircling
of a peripheral neuronal population responsible for regulating
itch and thermal pain transmission.
RESULTS
Restricted Vglut2 Deficiency Results in an Elevated Itch
Phenotype
Complete deletion of Vglut2 results in a disruption of respiratory
behavior after birth (Walle´n-Mackenzie et al., 2006); therefore,
tissue-specific promoter-driven Cre lines were needed to study
the role of VGLUT2 in pain and itch circuitry. For this purpose,
we generated mice lacking Vglut2 in neurons that express
tyrosine hydroxylase (Th) by using Th IRES-Cre mice (Figure S1,
available online). Apart from the expected Cre expression in
catecholaminergic neurons, expression also comprises several530 Neuron 68, 529–542, November 4, 2010 ª2010 Elsevier Inc.noncatecholaminergic neurons, presumably because of tran-
sient expression of tyrosine hydroxylase during development
(Lindeberg et al., 2004). To our benefit, the Cre activity in dorsal
root ganglion neurons affected 74% ± 1% of the Vglut2 popula-
tion (n = 6, 88 sections), which enabled the use of Th IRES-Cre
mice in our investigation. Vglut2f/f mice that were crossed with
Th IRES-Cre mice (Vglut2f/f;Th IRES-Cre) developed lesions in the
neck and upper back region (Figure 1A). Histological examina-
tion of the skin showed that wounded areas inVglut2f/f;Th IRES-Cre
mice displayed thickened epidermis of uneven psoriasiform
type, infiltration of immune cells in the dermis, and ulcerations,
findings that are typical outcomes of prolonged scratching and
rubbing. Areas without visual damage were similar to control
skin (Figures 1B–1E). This observation indicated that the abra-
sions to the skin were the result of an external force, i.e., exten-
sive scratching. Indeed, in 30min recordings, Vglut2f/f;Th IRES-Cre
mice displayed a chronic itch behavior, having 83.5 ± 14.9
scratch episodes/30 min compared to 31.9 ± 5.3 for controls
(p = 0.0006) (Figure 1F). Chronic itch is a common symptom in
systemic disorders that affect the kidneys, liver, or thyroid. To
evaluate a possible inner-organ-induced itch in our mice, we
analyzed plasma levels of creatinine, urea, alanine aminotrans-
ferase (ALAT), and tyroxine 4 (T4) in samples from Vglut2f/f;
Th IRES-Cre mice and controls. No differences in the levels of
creatinine, urea, or T4 were found, whereas the marker for liver
function, ALAT, was slightly elevated but still within the normal
reference interval (Loeb and Quimby, 1999), excluding
a systemic disorder as the underlying cause of the elevated
scratch behavior in Vglut2f/f;Th IRES-Cre mice (Figure 1G).
VGLUT2 Regulates Both Histamine-Dependent
and -Independent Itch
Histamine-dependent itch is caused by the release of histamine
from mast cells and is involved in allergic disorders. In some
pruritic conditions, for example in atopic dermatitis or psoriasis,
the symptoms of itch cannot be relieved by antihistamines and
are considered to have a histamine-independent origin (Ikoma
et al., 2006). To investigate whether the increase in itch sensation
was transmitted via the histaminergic pathway, we topically
applied the histamine receptor 1 selective antagonist diphenhy-
dramine to mice that had developed a robust scratching pheno-
type. This treatment significantly reduced the scratch behavior in
Vglut2f/f;Th IRES-Cremice (Figure 1H; 367±102 to 116±21 scratch
episodes/hr, p = 0.014). To evaluate a potential central mode
of action or sedating effect of diphenhydramine, we orally admin-
istered the blood-brain barrier impenetrant antihistamine
desloratidine. This experiment resulted in a similar reduction in
scratchingbehavior as thediphenhydramine treatment (Figure 1I;
666 ± 124 vs. 294 ± 89 scratch episodes/hr, p = 0.030), suggest-
ing that the observed chronic itch is, at least partially, transmitted
through histamine-sensitive primary afferents. Gastrin-releasing
peptide receptor (GRPR)-mediated signaling pathway in the
spinal cord dorsal horn has been shown to mediate primarily
nonhistaminergic itch, although GRPR neurons are required for
mediating both histamine-dependent and -independent itch
(Sun and Chen, 2007; Sun et al., 2009). To examine whether
VGLUT2 also regulates histamine-independent itch, we crossed
GRPRmutantmicewithVglut2f/f;Th IRES-Cremice. In controlmice,
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Figure 1. Vglut2f/f;Th IRES-Cre Mice Display a Chronic Itch Behavior that Is Both Dependent and Independent of Histamine
(A) The extensive scratching results in fur loss and wounds in the neck region and around the ears.
(B–E) PAS staining of the wounded areas displayed a thickened epidermis of uneven psoriasiform type, infiltration of immune cells in dermis, and ulcerations
(D and E) compared to control skin (B) and Vglut2f/f;Th IRES-Cre skin (C) from nonaffected areas. Scale bars represent 0.13 mm in (B–D) and 0.39 mm in (E).
(F) Vglut2f/f;Th IRES-Cre mice display a chronic itch behavior compared to control mice at 7 weeks of age (n = 35 for Vglut2f/f;Th IRES-Cre [grey], n = 34 for controls
[white]).
(G) Markers for kidney function (creatinine and urea, p > 0.05), thyroid function (T4, p > 0.05), and liver function (ALAT, p = 0.019) did not deviate from reference
values observed in different mouse strains of the same age (Loeb and Quimby, 1999) in Vglut2f/f;Th IRES-Cre mice.
(H and I) Topical antihistamine treatment reduced the level of scratch in Vglut2f/f;Th IRES-Cre mice that had developed a robust scratch phenotype (n = 12), as did
oral treatment with a peripherally active antihistamine (n = 12; the white bar represents before treatment and black bar represents after treatment).
(J) Removal of the GRPR reduces the itch in Vglut2f/f;Th IRES-Cre mice (n = 11).
Mann-Whitney test, two-tailed (F–I) and Kruskal-Wallis, Dunn’s post-hoc test (J). *p < 0.05, ***p < 0.001. Data are presented as mean ± SEM.
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Figure 2. The VGLUT2-Regulated Itch in Vglut2f/f;Th IRES-Cre Mice
Has a Pruriceptive Origin
(A) Vglut2mRNAwas lost in dorsal root ganglia but not in spinal cord or brain in
Vglut2f/f;Ht-Pa-Cre animals as evaluated by RT-PCR. n = 3/genotype.
(B) Vglut2f/f;Ht-Pa-Cre mice (grey) scratch 127 ± 35 times/30 min compared to
14.5 ± 3.3 for controls (white) at 10 weeks of age (p = 0.0007, n = 10).
Data in (A) and (B) are presented as mean ± SEM.
(C and D) The Th IRES-Cre/Vglut2-positive population overlaps with 70% of the
GRP-positive population in the dorsal root ganglia. Vglut2 in situ hybridization
on dorsal root ganglia cells from Th IRES-Cre;TaumGFP mice with at least one
intact Vglut2 allele combined with immunohistochemistry of b-gal (Th IRES-Cre
activity) and GRP (n = 3, 22 sections). The reporter line TaumGFP carries
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532 Neuron 68, 529–542, November 4, 2010 ª2010 Elsevier Inc.scratching behavior was consistently low (8.7 ± 3.7 scratches/
30 min), while in Vglut2f/f;Th IRES-Cre mice a robust scratching
behavior was detected (334 ± 80 scratches/30 min). In contrast,
the number of scratches decreased significantly in compound
Vglut2f/f;Th IRES-Cre;GRPR-/0 mice (98 ± 52 scratches/30 min,
p < 0.05 ANOVA; Figure 1J), indicating that a large part of the
itch sensation was relayed via the GRP-GRPR pathway in
Vglut2f/f;Th IRES-Cre mice. Hence, VGLUT2 regulates both hista-
minergic and nonhistaminergic itch, to a considerable extent
via the GRP-GRPR signaling pathway.
The VGLUT2-Regulated Itch Behavior
in Vglut2f/f;Th IRES-Cre Mice Has a Pruriceptive Origin
Th IRES-Cre is active both in the central nervous system (CNS) and
in primary afferent neurons (Lindeberg et al., 2004) (Figure S1),
and to discriminate between neurogenic (central) or pruriceptive
(peripheral) itch, we crossed Vglut2f/f mice with mice expressing
Cre under the peripherally active human tissue plasminogen
promoter (Ht-Pa)-Cre. Ht-Pa-Cre, which affects the entire DRG
population (Pietri et al., 2003), deleted Vglut2 from the primary
afferent neurons as expected but did not affect the levels of
Vglut2 in spinal cord or brain (Figure 2A). Such Vglut2f/f;Ht-Pa-Cre
mice displayed a profoundly increased itch behavior comparable
to the elevated itch in Vglut2f/f;Th IRES-Cremice, indicating that the
deletion of Vglut2 in the primary afferent neurons is sufficient to
cause the itch phenotype (Figure 2B). The GRP-containing
primary afferents relay pruriception to the dorsal horn, and,
to investigate a possible direct role of VGLUT2 in the GRP
pathway, we analyzed the overlap between GRP-, Vglut2-, and
Th IRES-Cre-positive neurons in the DRG with the reporter line
TaumGFP (Hippenmeyer et al., 2005). A larger part (70%) of the
GRP-positive neurons also possessed Th IRES-Cre activity and
expressed Vglut2 (Figures 2C and 2D and Table S1). This overlap
suggests that intrinsic VGLUT2-mediated neurotransmission
in the GRP population has a possible regulatory role in itch
sensation.
Removal of Vglut2Results inDecreased Thermal but Not
Mechanical Pain Sensation
We next investigated the consequence of disturbed VGLUT2-
mediated signaling for pain sensation. Vglut2f/f;Th IRES-Cre mice
displayed a decreased responsiveness to radiant heat assessed
by the Hargreaves test (13.7 ± 0.7 s compared to 8.7 ± 0.6 s
for controls, p < 0.0001), a phenotype also shared by the
Vglut2f/f;Ht-Pa-Cre mice (Figure S2). The heat pain phenotype ofa lox-STOP-lox-mGFP-IRES-NLS-LacZ-pA allele, which enables visualization
of Cre-expressing cell bodies and dendrites. Cre activity excises the lox-
flanked STOP cassette and thereby initiates the expression of a membrane-
bound version of GFP as well as nuclei-restricted b-gal protein (for further
details see Hippenmeyer et al., 2005). Green arrows indicate a Vglut2-nega-
tive/Th IRES-Cre-positive/GRP-positive cell, red arrows indicate a Vglut2-posi-
tive/Th IRES-Cre-negative/GRP-positive cell, and black and white arrows
indicate the affected GRP population where all markers colocalize. The
displayed section was selected to show several stain combinations while
the Venn diagram presents the averaged overlaps (for exact overlaps
see Table S1). **p < 0.001, Mann-Whitney test, two-tailed. The scale bar
represents 30 mm.
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Figure 3. Vglut2f/f;Th IRES-Cre Mice Are Less
Sensitive to Thermal but Not to Mechanical
Pain Sensation
(A and B) Vglut2f/f;Th IRES-Cre mice are less sensi-
tive to thermal pain compared to control mice
assessed by 53C hot plate (n = 20/genotype),
48C hot plate (n = 29 [Vglut2f/f;Th IRES-Cre],
n = 23 [controls]), and the Hargreaves test
(n = 21/genotype).
(CandD)Vglut2f/f;Th IRES-Cremicedisplayunaltered
mechanical pain behavior compared to control
miceassessedbyRandall-Selitto (n=21/genotype)
and von Frey (n = 21/genotype) (p > 0.05). Von Frey
measurements resulted in a mean value of 0.48 ±
0.05 g and 0.56 ± 0.07 g for Vglut2f/f;Th IRES-Cre
mice and littermate controls, respectively. The
mean weight that resulted in a withdrawal when
the Randall-Selitto test was used 203.4 ± 21.2 g
and 199.3 ± 18.3 g for Vglut2f/f;Th IRES-Cre mice
and littermate controls, respectively.
(E and F) Vglut2f/f;Th IRES-Cre mice are less sensi-
tive to inflammatory pain induced by formalin
injections (n = 31 [Vglut2f/f;Th IRES-Cre], n = 25
[controls]). The mean observed pain behavior in
the acute phase was 24.9 ± 1.8 s and 63.3 ±
5.6 s for Vglut2f/f;Th IRES-Cre mice and controls,
respectively, whereas the mean observed pain
behavior in the inflammatory phase was 99.1 ±
12.6 s and 267.0 ± 23.5 s. *p < 0.05, **p > 0.01,
***p < 0.001, Mann-Whitney test, two-tailed.
Data are presented as mean ± SEM.
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VGLUT2 in Pain and ItchVglut2f/f;Th IRES-Cre mice was further examined, and, consistent
with their reduced sensitivity to radiant heat, they also
responded more slowly in the hot plate test (Figures 3A
and 3B). The mean latency of withdrawal of hind paw, followed
by licking or biting, on a 53C hot plate was 22.6 ± 1.3 s and
12.6 ± 1.0 s for Vglut2f/f;Th IRES-Cre and controls, respectively
(p < 0.0001). To discriminate between the contribution from
TRPV1 or TRPV2, we also tested Vglut2f/f;Th IRES-Cre mice and
controls on a 48C plate, which should only activate the TRPV1
receptor (Caterina et al., 1997; Tominaga and Caterina, 2004)
(Figure 3A). The mean latency of hind paw withdrawal at 48C
was 45.4 ± 3.7 s and 33.4 ± 3.8 s for Vglut2f/f;Th IRES-Cre and
controls, respectively (p = 0.005), which indicates that
VGLUT2-mediated glutamatergic signaling also has a central
role in pain signaling via the TRPV1 population. The
pain measurements were carried out in mice of different ages
(7–27weeks), implying that the permanent loss of Vglut2 resulted
in a chronic reduction of thermal pain sensitivity. Vglut2f/f;
Th IRES-Cre mice also displayed a decreased sensitivity to inflam-
matory pain induced by formalin injections compared to control
mice (Figures 3E and 3F). The biphasic response induced by
formalin was observed both in Vglut2f/f;Th IRES-Cre mice and in
littermate controls, although it was significantly lower in theNeuron 68, 529–542,Vglut2f/f;Th IRES-Cre mice (p < 0.0001 for
both the first and the second phase). The
sensitivity to mechanical stimuli was
studied with the von Frey and Randall-
Selitto tests (Figures 3C and 3D). VonFrey measurements resulted in a mean value of 0.48 ± 0.05 g
and 0.56 ± 0.07 g for Vglut2f/f;Th IRES-Cre mice and littermate
controls, respectively, and the mean weight that resulted in
a withdrawal in the Randall-Selitto test was 203.4 ± 21.2 g and
199.3 ± 18.3 g for Vglut2f/f;Th IRES-Cre mice and littermate
controls, respectively. We did not find a significant difference
between the two groups in either mechanical test (p = 0.41
and p = 0.99, respectively), concluding that Vglut2f/f;Th IRES-Cre
mice were less sensitive to thermal and inflammatory pain but
showed a normal response to mechanical pain.
The Expression of Tyrosine Hydroxylase in Primary
Afferent Neurons Overlaps to a Large Extent
with the TRPV1 Population
Only 10%–15% of the DRG neurons in the adult mouse express
Th, and the more substantial deletion of Vglut2 from DRG
neurons we report here is probably due to developmental activity
of Th in other hitherto uncharacterized subpopulations during
development. We next sought to determine the overlap between
Th IRES-Cre, Vglut2, and two markers, calcitonin gene-related
peptide (CGRP) and TRPV1, for the peptidergic primary afferents
detecting noxious heat to better characterize subpopulations
affected by Th IRES-Cre activity (Caterina et al., 2000; MogilNovember 4, 2010 ª2010 Elsevier Inc. 533
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Figure 4. The Expression of Tyrosine Hydroxylase in Primary Afferent Neurons Greatly Overlaps with the TRPV1 Population
(A and B) The Th IRES-Cre/Vglut2 population overlaps with 74%of the TRPV1 population in the dorsal root ganglia. Vglut2 in situ hybridization on dorsal root ganglia
cells from Th IRES-Cre;TaumGFP mice with at least one intact Vglut2 allele combined with immunohistochemistry of b-gal (Th IRES-Cre activity) and TRPV1 (n = 3, 36
sections). The yellow arrow indicates a Vglut2-positive/Th IRES-Cre-positive/TRPV1-negative cell and black and white arrows indicate the affected TRPV1
population where all markers colocalize. The scale bar represents 33 mm.
(C) Size distribution of TRPV1-positive neurons (n = 3, 829 neurons).
(D and E) The Th IRES-Cre/Vglut2-positive population overlaps with 52% of the CGRP-positive population in the dorsal root ganglia. Vglut2 in situ hybridization on
primary afferent neurons from Th IRES-Cre;TaumGFPmicewith at least one intact Vglut2 allele combinedwith immunohistochemistry of b-gal (Th IRES-Cre activity) and
CGRP (n = 3, 30 sections). The green arrow indicates a Vglut2-negative/Th IRES-Cre-positive/CGRP-positive cell, the white arrow indicates a Vglut2-negative/
Th IRES-Cre-negative/CGRP-positive cell, and black and white arrows indicate the affected CGRP population where all markers colocalize. The scale bar repre-
sents 60 mm (for exact overlap see Tables S2:1 and S2:2).
(F) Topical application of capsaicin reduced the itch phenotype in Vglut2f/f;Th IRES-Cre mice (n = 14). Moreover, one topical application of capsaicin resulted in an
increase in the level of chronic itch the following day (p = 0.005), from 216 ± 43 scratch episodes/hr to 453 ± 50. Preapplication levels are in white and postap-
plication are in black. Data are presented as mean ± SEM. **p < 0.01, ***p < 0.001, Mann-Whitney test, two-tailed.
Neuron
VGLUT2 in Pain and Itchet al., 2005). Ablation of TRPV1 afferent neurons leads to a major
loss of CGRP immunoreactivity, which suggests coexpression
of CGRP and TRPV1 in DRG neurons (Cavanaugh et al., 2009).
Th IRES-Cre activity was shown to target 93% of the TRPV1 pop-
ulation (Figures 4A and 4B and Table S2:1), and Vglut2 mRNA
expression was observed in 77% of the TRPV1 population,
which resulted in a targeting of Vglut2 in 74% of the TRPV1
primary afferent neurons in Vglut2f/f;Th IRES-Cre mice. The tar-
geted population represented a majority of the small TRPV1534 Neuron 68, 529–542, November 4, 2010 ª2010 Elsevier Inc.neurons (60%, <250mm2), leaving approximately one-third of
the small TRPV1 population, which were devoid of Vglut2,
unaffected in the Vglut2f/f;Th IRES-Cre mice (Figure 4C). Th IRES-Cre
also targeted 84% of the CGRP population, which is in
further support of a substantial colocalization of CGRP and
TRPV1 (Figures 4D and 4E and Table S2:2). Thus, the consider-
able overlap between TRPV1/CGRP, Th IRES-Cre, and Vglut2
suggests that the observed thermal pain phenotype originates
from VGLUT2-mediated glutamatergic release through
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Figure 5. Generation and Characterization of a Mouse Expressing Cre Driven by the Trpv1 Promoter
(A) Schematic drawing of the BAC cloning for the generation of Trpv1-Cre transgenic mice. The following abbreviations are used: iCre, codon-improved Cre; F, frt
site; A, ampicillin resistance gene.
(B and C) Trpv1-Cre overlapped with 93% of the TRPV1-immunoreactive cells, which corresponds to 67% of the Trpv1-Cre-positive population (scale bar
represents 33 mm); the white arrow denotes TRPV1-immunoreactive cell without Trpv1-Cre activity, the green arrow indicates Trpv1-Cre active cell without
TRPV1-immunmoreactivity, and black and white arrows show some of the overlapping cells (n = 3, 20 sections). Fibers fromDRG neurons with TrpV1-Cre activity
were visualized with the TaumGFP reporter line and were predominantly found in the most dorsal lamina of the spinal cord (scale bar represents 60 mm).
(D) Dorsal root ganglia from Vglut2f/f;Trpv1-Cre mice (grey) displayed decreased expression of Vglut2 mRNA compared to controls (white) (p = 0.048, Student’s
two-tailed t test, n = 3/genotype). Data are presented as mean ± SEM.
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VGLUT2 in Pain and ItchTRPV1-positive neurons. Next, we tested the functional involve-
ment of the TRPV1 population on the displayed scratching
behavior by use of the TRPV1-selective agonist capsaicin. The
result of topical administration of capsaicin was assessed by
the number of scratch episodes before and 2 hr after the appli-
cation of capsaicin on Vglut2f/f;Th IRES-Cre mice. The use of
vehicle lotion did not result in a difference (from 216 ± 43 to
263 ± 68 scratch episodes/hr, p = 0.95) (Figure 4F). However,
administration of 0.1mgcapsaicin/g vehicle induceda significant
decrease in frequency of scratch episodes (from 307 ± 59 to 69 ±
16 scratches/hr, p < 0.0001). This effect was even more
pronounced with 1 mg capsaicin/g vehicle (from 453 ± 50 to
13.8 ± 5.2 scratches/hr, p < 0.0001). The clear effect of capsaicin
treatments on the VGLUT2-mediated induction of chronic itch
further corroborated a role for the TRPV1 population in the
observed sensory deficits.
Removal of Vglut2 from Trpv1-Cre-Positive Neurons
Results in Enhanced Itch and Decreased Thermal Pain
Sensitivity
TRPV1 is the receptor for capsaicin, the pungent component in
chili pepper, and has also been shown to respond to thermal
heat (Caterina et al., 1997). The role of the TRPV1 population
has previously been related to acute thermal pain sensitivity
and inflammation-induced thermal hyperalgesia (Caterina
et al., 1997; Cavanaugh et al., 2009). However, a large propor-tion of capsaicin-sensitive neurons also respond to the prurito-
gens histamine and chloroquine (Liu et al., 2009), which
suggests a dual role for this population in sensory transmission.
The large overlap between TRPV1 and Vglut2, together with the
reduced thermal pain phenotype and the elevated itch, promp-
ted us to further explore the role of VGLUT2 in this population
of neurons. For this purpose, we generated Trpv1-Cre trans-
genic mice by using a bacterial artificial chromosome (BAC)-
cloning strategy to insert a codon-improved Cre into the locus
of the first exon of Trpv1 (Figure 5A). Trpv1-Cre activity, visual-
ized as b-gal expression with the reporter line TaumGFP, was
found to largely overlap (93%) with TRPV1 immunoreactivity
in the primary afferent neurons (Figures 5B and 5C) and was
also detected in a small number of scattered neurons in spinal
cord and brain (Figure S3 and Table S5). To validate the
specific removal of Vglut2 in response to the detected
Trpv1-Cre activity, we measured Vglut2 mRNA expression in
the dorsal root ganglia by RT-PCR. This resulted in a significant
decrease of Vglut2 mRNA to approximately 40% of control
levels (Figure 5D).
Consistent with the overlap between Th IRES-Cre and TRPV1
populations, the deletion of Vglut2 from Trpv1-Cre-positive
neurons resulted in an increase of scratch episodes (157.1 ±
54.8 scratches/30 min for Vglut2f/f;Trpv1-Cre mice compared
to 21.0 ± 6.4 scratches/30 min for controls; Figure 6A and
Movie S1). Similarly, decreased thermal pain sensitivity in theNeuron 68, 529–542, November 4, 2010 ª2010 Elsevier Inc. 535
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Cre-Positive Neurons Results in Enhanced
Itch andDecreased Thermal Pain Sensitivity
(A) Vglut2f/f;Trpv1-Cre mice display an increased
scratch behavior compared to control mice
(p = 0.0015, n = 10/genotype, age 7–9 weeks).
(B) Vglut2f/f;Trpv1-Cre mice are less sensitive to
thermal pain compared to control mice (p =
0.0002, n = 16/genotype).
(C and D) Vglut2f/f;Trpv1-Cre mice do not display
amechanical pain phenotype compared to control
mice in von Frey (p = 0.24, n = 8/genotype) or
Randall-Selitto tests (p = 0.71, n = 8/genotype).
The mean weight that resulted in a withdrawal
was 0.64 ± 0.13 g and 0.87 ± 0.17 g in the von
Frey test and 179.3 ± 12.0 g and 185.0 ± 14.5 g
in the Randall-Selitto test for Vglut2f/f;Trpv1-Cre
mice and littermate controls, respectively.
(E and F) Vglut2f/f;Trpv1-Cre mice display no differ-
ence in formalin-induced inflammatory pain
behavior compared to control mice (n = 8/geno-
type). The mean observed pain behavior in the
acute phase I was 52.8 ± 7.6 s and 67.0 ± 6.4 s
(p = 0.16), whereas the mean observed pain
behavior in the inflammatory phase II was
212.8 ± 34.5 s and 300.1 ± 40.1 s (p = 0.16) for
Vglut2f/f;Trpv1-Cre mice and controls, respectively.
Data are presented as mean ± SEM. **p < 0.01,
***p < 0.001, Mann-Whitney test, two-tailed.
(G and H) The downstream effect on spinal cord
central interneurons was tested by determining
the number of c-Fos activated neurons (white
arrows) in response to thermal stimulation. Dele-
tion of Vglut2 from Trpv1-Cre primary afferents
results in a reduced number of c-Fos-activated
interneurons in lamina I and II in the L2 segment
after Hargreaves stimulation (n = 2/genotype, 150
sections). The scale bar represents 30 mm.
Neuron
VGLUT2 in Pain and ItchHargreaves test (13.7 ± 1.5 s for Vglut2f/f;Trpv1-Cre mice compared
to 7.7 ± 0.7 s for controls) was also observed (Figure 6B).
Mechanical pain sensitivity, assessed by Randall-Selitto and
von Frey tests, did not differ between Vglut2f/f;Trpv1-Cre mice
and controls (Figures 6C and 6D) nor did inflammatory pain
sensitivity induced by formalin (Figures 6E and 6F). Thus, all
investigated sensory modalities, except thermal pain and
itch, were unaffected. In light of our data from the Vglut2f/f;
Th IRES-Cre analysis, our examination of Vglut2f/f;Trpv1-Cre mice
supports the interpretation that the reduced thermal pain sensi-
tivity and the increased scratch behavior were due to the loss
of VGLUT2-mediated glutamatergic neurotransmission in the
Trpv1-Cre population. In order to strengthen this conclusion,
we investigated the downstream effect of an expected impaired
glutamate release in the spinal cord dorsal horn by counting the
number of c-Fos neurons after thermal heat stimulation using
the Hargreaves test. The c-Fos immediate early gene is induced
by neural excitation and can be used as an activation marker for
neurons in the superficial dorsal horn of the spinal cord down-
stream of primary afferent stimulation (Hunt et al., 1987). The536 Neuron 68, 529–542, November 4, 2010 ª2010 Elsevier Inc.most prominent c-Fos response was detected in lamina I/II in
lumbar level 2 (Figure S4), consistent with the location of Trpv1-
Cre;TaumGFP-labeled central projections (Figure 5B). The number
of c-Fos-positive nuclei detected in Vglut2f/f;Trpv1-Cre mice was
significantly decreased when compared to control mice
(Figures 6G and 6H; p < 0.001). The decrease was profound
in lamina I (10-fold) and II (5-fold), while the decrease detected
in lamina III was small and not significant. Thus, the Trpv1-
Cre-driven Vglut2 deletion significantly decreased the number
of c-Fos-responding dorsal horn interneurons, suggesting that
the reduced Vglut2 levels led to decreased downstream
activation.
Loss of Vglut2 in the Nav1.8 Population, Partially
Overlapping with the TRPV1 Population, Affected
Neither Spontaneous Itch nor Thermal Pain
So far, our data have demonstrated that removal of Vglut2 from
Trpv1-Cre-positive neurons results in an elevated itch pheno-
type accompanied by a decrease in thermal pain sensitivity.
A population partially overlapping with TRPV1 is the Nav1.8
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Figure 7. Vglut2f/f;Nav1.8
Cre Mice Do Not
Display Spontaneous Itch or Altered
Thermal Pain Response
(A) Overlap between Vglut2 mRNA, Nav1.8
Cre
activity, and TRPV1 immunoreactivity was de-
tected using cryo in situ hybridization combined
with immunohistochemistry. Nav1.8
Cre activity
was assessed, through b-gal immunoreactivity
using the reporter mouse TaumGFP. Yellow arrows
denote Vglut2 mRNA-positive/Nav1.8
Cre-positive/
TrpV1-negative cells. Red arrows denote a Vglut2
mRNA-positive/Nav1.8
Cre-negative/TrpV1-posi-
tive cell. White arrows display a Vglut2-negative/
Th IRES-Cre-negative/TrpV1-positive cell. Black
and white arrowheads denote triple-labeled cells.
The scale bar represents 33 mm.
(B) Venn diagram displaying the overlap between
Nav1.8
Cre, Vglut2, and TRPV1 (n = 2, 35 sections),
for exact overlap see Table S3.
(C) Thermal heat pain was assessed by the
Hargreaves test (n = 14 [controls], n = 13
[Vglut2f/f;Nav1.8
Cre]) and did not differ between
the groups (p = 0.09).
(D) Vglut2f/f;Nav1.8
Cre mice displayed an unal-
tered spontaneous itch behavior compared to
control mice at 7 weeks (n = 10/genotype,
p = 0.26, Mann-Whitney test, two-tailed) and at
9–11 weeks of age (n = 10/genotype, p = 0.94).
(E) Vglut2f/f;Nav1.8
Cre mice initially displayed an
increased response to intradermal injections of
the pruritogen 48/80 (100 mg) or NaCl compared
to control mice (n = 8/genotype). *p < 0.05,
Mann-Whitney test, two-tailed.
Data in (C), (D), and (E) are presented as mean ±
SEM.
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VGLUT2 in Pain and Itchpopulation, which, in addition to the pain-mediating role, has
also been suggested to provide a basal level of activity to
balance itch pathways (Roza et al., 2003). TRPV1 and Nav1.8
Cre
populations positive for Vglut2 overlap with 56% (Figures 7A
and 7B and Table S3), indicating that these populations might
overlap in their functionalities. However, deletion of Vglut2 in
Nav1.8
Cre-positive neurons did not result in a significant
increase in spontaneous scratching behavior or in an altered
thermal pain response (Figures 7C and 7D). A tendency toward
a spontaneous increase in scratching behavior was noted at
both ages investigated (Figure 7C), and, similarly, a tendency
to decreased thermal pain response could be noted and
possibly be explained by a partial loss of Vglut2 in the TRPV1
population. To further investigate potential defects in pruricep-
tion, we provoked itch sensation with the pruritogen 48/80.
This irritant led to a significantly higher number of scratching
bouts in Vglut2f/f;Nav1.8
Cre mice compared to control mice
(Figure 7E). Notably, the difference in provoked sensitivity
rapidly subsided, suggesting that mice lacking Vglut2 in the
Nav1.8
Cre population, affecting only 56% of the TRPV1 popula-
tion, retained the ability to regulate itch sensation, albeit with
a disturbed and delayed response.Expression of Vglut2, Trpv1-Cre, and GRP Suggests the
Presence of DualModality Afferents aswell as Afferents
Selective for Thermal Pain or Itch
To test whether the presence of the itch-selective GRP trans-
mitter in Trpv1-Cre neurons could shed light on the perceived
dual role of the TRPV1 subpopulation, we performed fluores-
cent Vglut2 in situ combined with GRP and b-gal immunohisto-
chemistry on DRG sections from Trpv1-Cre;TaumGFP mice. The
analyses defined one small GRP population negative for
Trpv1-Cre (9% of the GRP population), which is likely to
mediate itch sensation independent of TRPV1 (Figures 8A
and 8B). Further, we found a large Trpv1-Cre population nega-
tive for GRP (56% of the Trpv1-Cre population), which, in the
absence of other known primary afferent itch transmitters,
suggests the presence of thermal-pain-selective fibers. Finally,
we defined two different subpopulations involving Vglut2 in the
Trpv1-Cre neurons, which could provide an explanation for
the observed pain and itch phenotypes in our Vglut2-deficient
mice: a GRP-negative population (44%) that represents
a VGLUT2-dependent thermal-pain-selective population and
a GRP-positive population (56%), which, considering the
demonstrated roles of GRP in itch and TRPV1 in thermal painNeuron 68, 529–542, November 4, 2010 ª2010 Elsevier Inc. 537
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Figure 8. Overlap Analysis of Vglut2, Trpv1-Cre and
GRP Suggests the Presence of Dual Modality Affer-
ents as well as Afferents Selective for Thermal Pain
or Itch
(A and B) GRP overlap in the Trpv1-Cre/Vglut2-positive popu-
lation defines two subpopulations: one Trpv1-Cre/Vglut2
population (44%) and one Trpv1-Cre/Vglut2/GRP (56%)
population in the dorsal root ganglia. Vglut2 in situ hybridiza-
tion on primary afferent neurons from TrpV1-Cre;TaumGFP
mice with at least one intact Vglut2 allele combinedwith immu-
nohistochemistry of b-gal (Trpv1-Cre activity) and GRP (n = 2,
20 sections) (scale bar represents 80 mm), for exact overlap
see Table S4.
(C) Schematic drawing of possible Vglut2-, GRP-, and/or
TRPV1-mediated neuronal interactions regulating itch.
TRPV1-positive thermal nociceptive primary afferents (green)
transmit pain, for example by scratching, and GRP-positive
pruriceptors (grey) transmit itch from a pruritogen-induced
stimuli. VGLUT2-mediated release of glutamate from
a TRPV1 subpopulation (dark red) of neurons may prevent
excessive scratching by activating inhibitory interneurons
projecting to GRPR-positive neurons. Additionally, fibers
capable of transmitting both pain, through glutamate, and
itch, through GRP, are present (yellow). The two gray boxes
represent the thermal pain and the itch pathways, respec-
tively.
(D) Summary of thermal pain and itch phenotypes, in relation to
the TRPV1 population, after conditional ablation of Vglut2 with
denoted Cre lines. UBased on the overlap between Trpv1-Cre
and Vglut2 (Table S4). VProvocable itch.
Neuron
VGLUT2 in Pain and Itch(Caterina et al., 1997, 2000; Sun and Chen, 2007; Sun et al.,
2009), suggests the presence of dual modality fibers
(Figure 8C and Table S4).
DISCUSSION
Using several geneticmousemodels,which lackVglut2 in various
subpopulations of DRG neurons, we provide evidence that self-
inflicted wounds in the skin of these mutant mice were caused
by an incessant spontaneous scratching behavior. The increased538 Neuron 68, 529–542, November 4, 2010 ª2010 Elsevier Inc.scratching behavior was significantly reduced by
antihistamine treatments or loss of the GRP
receptor, which suggests that the chronic scratch
behavior originated in an elevated itch transmission
comprising both histamine-dependent and -inde-
pendent components. Using extensive colocaliza-
tion studies of Vglut2 expression with markers for
primary afferent subpopulations, we demonstrate
a major overlap with the thermal-pain-responsive
TRPV1-positive population. This analysis also
provides evidence of two separate TRPV1 subpop-
ulations of neurons based on their differential
expression of GRP. Further, we show that the
permanent loss of Vglut2 in the investigated mouse
lines leads to decreased thermal pain perception.
The use of the Ht-Pa-Cre mouse line helped deter-
mine that the increased VGLUT2-dependent itch
originated from the periphery while the analysesfrom Th IRES-Cre and Trpv1-Cre mouse lines both include most
of the TRPV1-positive neurons, strengthening the involvement
of the TRPV1 population in the regulation of itch. Moreover, we
have demonstrated that loss of Vglut2 in the Nav1.8 population
did not affect spontaneous itch or thermal pain sensitivity. Our
data lead us to conclude that both thermal pain sensation and
regulation of itch transmission are dependent on VGLUT2-medi-
ated glutamatergic neurotransmission in TRPV1-positive
neurons and that thermal, but not mechanical, pain and itch
transmission might be connected.
Neuron
VGLUT2 in Pain and ItchCaveats in this study that need further discussion include the
complex interpretation of the reduced itch in response to capsa-
icin (Figure 4F). Capsaicin is known to acutely induce pain
through the TRPV1 receptor but has also been reported to evoke
itch (Sikand et al., 2009). In addition, prolonged treatment with
capsaicin can desensitize pain fibers; for example, intrathecal
administration of capsaicin has been used to desensitize the
central branch of primary afferents of TRPV1 neurons (Cava-
naugh et al., 2009). Thus, the sensory response to capsaicin
can vary depending on dosage, location, and route of adminis-
tration. While the reduced scratching behavior in our mice
produced by capsaicin treatment corroborates a role for the
TRPV1 population in VGLUT2-mediated itch regulation, further
experiments are needed to determine the particular mechanism
behind this behavioral change. Second, while the reduced c-fos
response clearly indicates aberrant signaling in the dorsal horn of
Vglut2f/f;Trpv1-Cre mice, it will ultimately be important to assess
glutamatergic transmission with electrophysiological methods.
A third caveat is the possible confounding factor of an increased
scratch behavior in the analysis of pain behavior. To address this
issue, we analyzed a possible association between scratching
intensity and pain response. We decided to analyze the
response to formalin since it contains two analyzable phases
and has the longest duration. The excessive scratch behavior
in the neck and upper back region would have the largest impact
in a pain test occupying the longest space of time. However, no
correlation between an increased itch and a pain response was
found in either the acute or the inflammatory phase (Figure S2).
Previous studies have shown that capsaicin-induced ablation
of TRPV1 afferents causes a partial loss of heat pain sensitivity
(Jessell et al., 1978). The role of TRPV1 for transmission of
heat nociception has been further substantiated by investigating
TRPV1 knockout mice (Caterina et al., 1997; Davis et al., 2000),
and we here report that normal heat pain sensation transmitted
via the TRPV1 population requires VGLUT2 (Figure 6). In addition
to its role in thermal pain, transmitted by the TRPV1 population,
VGLUT2 is critical for a normal response to mechanical pain
transmitted by the Nav1.8 subpopulation (unpublished data).
Notably, Vglut2f/f;Nav1.8-Cre mice have a normal response to
thermal pain and do not display increased spontaneous scratch-
ing (Figure 7). Likewise, Vglut2f/f;Th IRES-Cre or Vglut2f/f;Trpv1-Cre
mice have a normal response to mechanical pain (Figures 3
and 6). The TRPV1 and the nonpeptidergic C fiber Mas-related
gene D (MrgD) neurons are predominantly nonoverlapping pop-
ulations while the MrgD and Nav1.8 neurons are largely overlap-
ping (82%; unpublished data). Mice that had lost the MrgD-posi-
tive population, through acute diphtheria toxin ablation, show
a decreased sensitivity to mechanical sensation (Cavanaugh
et al., 2009). In a similar experiment, except for the nonacute
administration of diphtheria toxin, MrgD cell-ablated mice do
not show different responses to pruritogens, suggesting, if the
deletion of the MrgD population has not been compensated for
during development, that these neurons are not involved in the
regulation of itch (Imamachi et al., 2009). Thus, our data together
with previous observations argue for a link between itch and
thermal, but notmechanical, pain through the TRPV1 population.
We here establish that VGLUT2 in the TRPV1 population is
required to restrain itch sensation and for normal thermal painsensitivity. The observed increase in itch behavior implies that
VGLUT2 expression in Trpv1-Cre-positive sensory neurons is
dispensable for itch sensation. How can the reduction of
VGLUT2-mediated transmission within the TRPV1 afferents
lead to increased itch and decreased pain, either dependent or
independent of each other? The opposite responses to reduced
VGLUT2 transmission rule out the intensity theory. Rather, our
data suggest the copresence of itch/pain dual modality fibers
with pain-selective fibers (selectivity theory), where reduced
VGLUT2 transmission would lead to reduced activity in pain-
selective afferent fibers. In support of this, 44% of the
Trpv1-Cre/Vglut2 population does not contain GRP (Figure 8
and Table S4), which includes the possibility of a thermal-noci-
ceptive-selective population. Consequently, a larger part, 56%,
of the Trpv1-Cre- and Vglut2-positive neurons is GRP positive
and this extensive overlap between GRP, Vglut2, and TRPV1
indicates a possible cotransmission of glutamate and GRP. As
such, these neurons represent possible dual modality fibers
where the pruriceptive signal could primarily be mediated by
GRP while it is regulated by VGLUT2-dependent glutamatergic
signaling. It is also possible that the observed coincident
increase in itch sensation is mediated by a TRPV1-independent
population of GRP neurons (9%). It was recently shown that
neurons sensitive to capsaicin overlap extensively with histamin-
ergic, as well as nonhistaminergic, pruriceptive neurons (Liu
et al., 2009) and that the TRPV1 population responds to various
pruritogens through several mechanisms (Imamachi et al., 2009).
In humans, capsaicin has been shown to acutely elicit both itch
and pain when administered via spicules in a single dose (Sikand
et al., 2009). Further, the majority of the primary afferents inves-
tigated in humans responding to histamine also responded to
intracutaneous injection of capsaicin (Schmelz et al., 1997), sug-
gesting that the TRPV1 population can transmit both modalities.
Our data provide evidence that VGLUT2-mediated glutamater-
gic neurotransmission is critical for thermal pain sensation in
the TRPV1 population. Taking all of the above into account, the
evidence for the presence of itch-mediating neurons within the
TRPV1 population is overwhelming. Therefore, we here suggest
that the pruritic capacity within the TRPV1 population is, most
likely, transmitted by GRP and that primary afferents exist that
can regulate itch through VGLUT2-mediated glutamatergic
release.
How can the increased itch sensation be explained by
a decrease in excitatory activation? A heightened activity in the
itch pathway could be due to reduced glutamatergic excitation
of spinal cord dorsal horn inhibitory interneurons. In this
scenario, excessive pruriception would be suppressed by
parallel inputs via pain-sensitive fibers activated by scratching.
A small pruritic skin abrasion would under normal circumstances
induce a scratch response to sufficiently reduce the itch sensa-
tion, allowing for periods of healing. However, when the parallel
input mediated by VGLUT2 is reduced, this causes the initiation
of injurious skin-scratch cycles, resulting in the severe skin
wounds observed in the Vglut2-deficient mice. This hypothesis
assumes the presence of a mechanism, or interneuron popula-
tion, capable of transforming the excitatory glutamatergic
activity released by the TRPV1 population to an inhibitory influ-
ence on pruriception. Until very recently, no such mechanismNeuron 68, 529–542, November 4, 2010 ª2010 Elsevier Inc. 539
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VGLUT2 in Pain and Itchor population of interneurons had been identified. The revelation
of dorsal inhibitory interneurons capable of regulating itch
behavior (Ross et al., 2010) supplies evidence for a component
in itch regulation necessary for recognizing a model of disinhibi-
tion (Figure 8D). The itch phenotype of the mutant mice
presented in this study was similar to the increased itch dis-
played by the Bhlhb5mouse mutant, in which, once a very small
skin irritation appeared, the persistent licking and scratching
very soon thereafter resulted in a skin lesion (Ross et al., 2010).
In summary, removal of VGLUT2-mediated glutamatergic
signaling in a subset of primary afferent neurons coinciding with
the TRPV1 and GRP populations results in a decrease in thermal
pain while mechanical pain is unaffected. We conclude that
thermal pain, as opposed to mechanical pain, could be part of
an intricate interplay with itch sensation within the TRPV1 popu-
lation. The present study provides a basis for a mechanism
involved in regulating itch and defines a neuronal population
and a neurotransmitter that can mediate this effect and, as
such, is a starting point for further experiments of somatosensory
interactions through tissue-specific ormolecule-specific ablation
studies. For example, cell-specific ablation of the TRPV1
population will provide information to dissociate the roles of
itch-selective and itch/pain polymodal fibers in the regulation of
pruriception. In a more clinical perspective, the rescue of chronic
itch by interfering with the GRP-GRPR pathway suggests that
GRPR antagonists could be useful for treating chronic itch
conditions.EXPERIMENTAL PROCEDURES
Generation of Transgenic Vglut2 Animals
Mice homozygous for the floxed allele for Vglut2 (Vglut2f/f) (Walle´n-Mackenzie
et al., 2006) were crossed with ThIRES-Cre mice (Lindeberg et al., 2004) to
generate mice lacking Vglut2 in Th-expressing neurons (Vglut2f/f;ThIRES-Cre)
and controls (Vglut2f/f). Male Vglut2f/f;ThIRES-Cre mice were crossed with the
reporter mouse TaumGFP (Hippenmeyer et al., 2005) to identify ThIRES-Cre-posi-
tive neurons. Male Vglut2f/f;ThIRES-Cre mice were also crossed with GRPR
mutant females (Sun and Chen, 2007) to generate Vglut2f/f;ThIRES-Cre mice
lacking the GRPR receptor (Vglut2f/f;ThIRES-Cre;GRPR-/0, GRPR is X-bound).
Vglut2f/f females were also crossed with the periphery-specific Cre line
Ht-Pa-Cre (kindly provided by professor Sylvie Dufour) (Pietri et al., 2003) or
the primary afferent-specific Cre line Nav1.8-Cre (Stirling et al., 2005) to
generate Vglut2f/f;Ht-Pa-Cre or Vglut2f/f;Nav1.8
Cre mice, respectively. Trpv1-Cre
mice were generated by recombineering of BAC DNA (Supplemental Experi-
mental Procedures).Multiplex Single-Cell RT-PCR
Dorsal root ganglia were dissected and dissociated from Vglut2f/f;Th-IRES-Cre;
TaumGFP P2 pups, and GFP-expressing cells were individually collected. The
content of each cell was analyzed by a first round of PCR, followed by a second
round with 10% of the first PCR reaction. Primers were designed to bind in
different exons; therefore, they detect only mRNA and do not interact with
each of the other primers in themultiplex PCR (see Supplemental Experimental
Procedures for further details).qPCR
Quantitative real-time PCR on homogenate from dissected dorsal root ganglia
(Vglut2f/f;Trpv1-Cre, Vglut2f/f;Ht-Pa-Cre), spinal cord (Vglut2f/f;Ht-Pa-Cre), and brain
(Vglut2f/f;Ht-Pa-Cre) and from control mice was performed as described previ-
ously (Olszewski et al., 2009) with some exceptions (see Supplemental Exper-
imental Procedures).540 Neuron 68, 529–542, November 4, 2010 ª2010 Elsevier Inc.Histology and Blood Analyses
Adult mice (>7 weeks old) were perfused as previously described (Gezelius
et al., 2006), and skin was isolated. Sections were stained with hematoxylin
and eosin (H&E) and periodic acid-Schiff (PAS) for a histopathological evalua-
tion (see Supplemental Experimental Procedures for further details).
Probes
The generation of the in situ probes is described elsewhere (Gezelius et al.,
2006). The Vglut2 probe covers nucleotides 1616–2203 (NM_080853.2) and
was used at a concentration of 1000 ng/ml. Vesicular acetylcholine transporter
(Vacht) probe covers nucleotides 1534–2413 (NM_021712) and vesicular
inhibitory amino acid transporter (Viaat) probe covers nucleotides 1578–
1889 (NM_009508.1).
In Situ Hybridization and Immunohistochemistry
Primary antibodies used were chicken anti-b-galactosidase (b-gal) 1:5000
(Abcam), rabbit anti-CGRP 1:1000 (Peninsula Labs), rabbit anti-TRPV1
1:1000 (Abcam), and rabbit anti-GRP 1:1000 (ImmunoStar). Secondary
antibodies were goat anti-chicken Alexa 488 1:400 (Invitrogen) and goat
anti-rabbit Alexa 647 1:400 (Invitrogen). Cryo in situ was performed as
described previously (Schaeren-Wiemers and Gerfin-Moser, 1993) with
a few exceptions. For staining of lumbar spinal cord sections, primary
antibodies used were anti-GFP 1:1000 rabbit (Invitrogen) or chick (Abcam),
NeuN 1:400 mouse (Millipore), and goat anti-c-Fos 1:200 (Santa Cruz) and
secondary antibodies were goat anti-chicken Alexa 488 1:400 (Invitrogen),
goat anti-rabbit Alexa 488 1:200 (Invitrogen), goat Cy3 anti-mouse 1:500 (Invi-
trogen), and donkey anti-goat 488 Alexa 1:150 (Invitrogen) (see Supplemental
Experimental Procedures for further details).
Imaging
Fluorescent images were viewed in an Olympus BX61WI microscope and
analyzed with Volocity software (Improvision).
Behavior Analyses
General Behavior
All behavioral tests were performed on adult (>7 weeks old) female and male
mice. Control mice were littermates and gender matched. All behavior anal-
yses were performed in a controlled environment of 20–24C, 45%–65%
humidity, and 12 hr day/night cycle. All animal procedures were approved
by the local ethical committee in Uppsala, Sweden (permits C12/9, C79/9,
C98/7, C125/8, C147/7, C195/8, C198/7, C156/4, C210/7, C251/6, C256/9,
and C269/6) and followed the guidelines of European Communities Council
Directive (86/609/EEC).
Pain Behavior
Hot Plate Test. The latency of withdrawal of hind paw followed by licking or
biting of the paw at 48.0–48.2C (warm plate) or 52.5–53.0C (hot plate) was
measured two times for each animal, separated by at least 15 s. Results
were expressed as mean withdrawal latency for each animal and group ±
the standard mean error (SEM) (see Supplemental Experimental Procedures
for further details).
Hargreaves Test. The Hargreaves heat source (IITC Life Science) was placed
with the guide light pointing toward the plantar surface of the left hind paw and
the thermal beam was started. A paw withdrawal would stop the test and the
timewasmonitored. The result was expressed as themeanwithdrawal latency
time for each animal and group ± SEM. For assessment of c-Fos induction,
both hind paws were exposed to the thermal beam until pain behavior was
observed (3–5 min between each paw). The mice were then left in the setup
for 1 hr before perfusion (previously described in Gezelius et al., 2006). Spinal
cords were dissected out and prepared for cryosectioning (see above).
Von Frey Test. The Von Frey filaments (ScientificMarketing Associates) were
applied with the Chaplan ‘‘up-and-down paradigm’’ (Chaplan et al., 1994). The
50% threshold was calculated with the Dixonmethod and the result expressed
as the mean value for each animal and group ± S.E.M.
Randall-Selitto Test. The tail was gently placed under the Randal-Selitto arm
(Ugo Basile) before an increasing weight was applied to the tail. The weight for
which the mouse would withdraw its tail was monitored. The result was
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VGLUT2 in Pain and Itchexpressed as the mean withdrawal latency in grams for each animal and
group ± SEM.
Formalin Test. Twenty microliters of 5% formalin (35% formaldehyde
[Sigma] in 0.9% saline [Fresenius Kabi]) was injected subcutaneously into
the plantar surface of the right hind paw with a Hamilton microsyringe (1710
TLL 100 ml) with a 30G needle (BD Microlance). The mouse was observed in
a transparent cage for the following 60 min to monitor pain behavior, licking,
and biting of the injected paw.
Itch Behavior
The behavior was recorded with a digital video camera for 30min (chronic itch)
or 1 hr (treatment of itch behavior). One bout of scratching by either hind paw
was defined as a scratching episode. The result was expressed as the mean
number of scratch episodes for each group/30 min ± SEM (see Supplemental
Experimental Procedures for further details).
Treatment of Itch Behavior
Topical Treatments. For the treatment with vehicle and diphenhydramine (1%),
mice were recorded for 1 hr prior to the first topical application. Each admin-
istration was performed twice/day with a 4 hr interval and repeated for 5 days.
The treatment ended with a 1 hr recording of each mouse 1 hr after the last
application (see Supplemental Experimental Procedures for further details).
Oral Treatment.Mice were recorded for 1 hr prior to the first oral administra-
tion of NaCl or desloratadin (Aerius0.5 mg/ml [Schering-Plough]). Each admin-
istration of 5 mg/kg was performed once/day with a 40 mm straight feeding
needle (Agnthos) and repeated for 5 days (the volume NaCl used corre-
sponded to the volume Aerius for each animal). The treatment ended with
a 1 hr recording of each mouse 1 hr after the last application.
Provocation of Itch. Vglut2f/f;Nav1.8
Cre and control mice were recorded for
1 hr before they were injected intradermally with 50 ml NaCl with a 100 ml
Hamilton syringe supplied with a 30G1/2 needle. The animals were then rere-
corded for 1 hr. The following day, the animals were again recorded for 1 hr
before they were injected intradermally with 100 mg 48/80 dissolved in 50 ml
NaCl. The protocol ended with a 1 hr recording of each mouse directly after
the injection.
Statistics. Nonparametric calculations of p values (%2 groups) were con-
ducted with a Mann-Whitney test, two-tailed (Prism version 5.01, GraphPad
Software). Nonparametric calculations of p values (R2 groups) were con-
ducted with Kruskal-Wallis (1-way ANOVA) followed by Dunn’s post-hoc test
(Prism version 5.01, GraphPad Software).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, five tables, and onemovie and can be found with this article online
at doi:10.1016/j.neuron.2010.09.016.
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